In 1950, the Nomenclature Committee of the International Association of Microbiologists classified Neisseria meningitidis into four serological groups (2) . Group A corresponded to the old types I and III of Gordon and Murray (8) ; group B corresponded to type II of Gordon and Murray. Group C was defined as an independent serological group by agglutination, presence of a capsule (typical group B strains do not exhibit capsules), and inability of group C antiserum to protect mice challenged with group B strains (5) . Group D corresponded, to some extent, with the type IV of Gordon and Murray, but it occurred so rarely that its relationship with other serogroups is vague.
Since 1963, the incidence of meningococcal infections in the United States has increased (7) . The majority of isolates, from patients with meningococcal disease and healthy carriers of these bacteria, were typed as group B. Occasionally group C isolates were found, and very rarely isolates were of group A. In the past 2 years, however, there has been an increasing number of isolates that could not be typed by groups A, B, C, or D antisera obtained from commercial sources or prepared in our laboratory. At present these nontypable isolates constitute a new serogroup of N. meningitidis, and we suggest that they be called group E.
MATERIALS AND METHODS
Microorganisms. The strains of N. meningitidis chosen for use in our study were only strains that were virulent for mice so that satisfactory mouse protective antibody studies could be carried out (Table 1) .
The isolates were maintained within two to five passages from the original source material by storing the cultures at -65 C (18) in Trypticase Soy Broth (TSB; BBL). Initial serological grouping was based on macroscopic agglutination with rabbit antisera to the following prototype strains: group A (strain 1027), group B (strain 2091), group C (strain 1628), group D (strain M168), and group E (strain SD4C). The last strain was isolated from a patient in 1964. Group D was dropped from the study because no recent isolates were available, and the two strains obtained from the collection of the late Sarah Branham (strains M168 and M 169) were avirulent for mice (LDS > 106 bacteria).
Halo precipitation was determined by incorporation of 0.8 ml of antiserum per 10 ml of Mueller-Hinton (MH) agar (Difco) in plates (13) , and wet, India ink preparations were made as described by Duguid (6) .
Virulence assay. Virulence for mice was established by the technique of Miller (12) with 4% gastric mucin (Nutritional Biochemicals Corp., Cleveland, Ohio; lot 9801). Groups of six mice per dilution of bacteria were observed for 96 hr; all the dead animals were examined for intercurrent infection by smear of peritoneal exudate.
Sera. Rabbits were inoculated with lysed cell preparations of the isolates listed in Table 1 . The isolates were cultured on MH slants overnight (37 C, 8% C02, 100% humidity), and the growth was harvested with TSB. The inoculum was adjusted to give a final concentration of 107 cells per ml in 100 ml of TSB. After 4-hr incubation at 37 C with shaking, the cells were harvested in the log phase; they were washed twice with saline and were resuspended in saline to 109 cells per ml. Complete autolysis occurred after 7-day storage at 4 C. Each week, rabbits received a 1-ml dose of this mixture intraperitoneally followed 24 hr later by 1-ml doses intravenously daily for 2 days. This schedule was repeated for 3 weeks followed by 1 week of rest; then it was repeated for 1 week. Sera 1300 GROUP E NFISSERIA MENINGITIDIS employed in this study were obtained 10 days after the last injection.
The mouse-protective capacity of sera was determined by the technique of Branham (4) . At 0.5 to 2 hr before intraperitoneal injection of the test bacteria suspended in mucin, 1 ml of various dilutions of heatinactivated serum in saline was injected intraperitoneally. Mice were challenged with 100 to 10,000 minimal lethal doses (MLD). The number of mouseprotective units was defined as the reciprocal of the highest serum dilution which protected 50% of the challenged mice. Mice in separate control groups were inoculated with 0.15 M saline or a 1:10 dilution of normal rabbit serum before receiving the challenge dosage of bacteria.
Serology. Macroscopic agglutination was performed by mixing 0.05 ml of cell suspension (0.15 M phosphate buffer with 0.5% phenol, pH 6.8) with 0.05 ml of undiluted serum. We read the results after 5 min at room temperature. Normal rabbit serum and saline were used as controls.
We employed the same complement-fixation (CF) technique used by Terzin et al. (16) . The CF titers of all sera were determined with 4 units of antigen.
The precipitin content of sera was established by the capillary technique (15) . The cell debris in the lysed cell preparation was removed by centrifugation, and equal volumes of the supernatant liquid and heatinactivated sera were drawn into the capillary. The amount of precipitate was recorded after incubation for 4 hr at 37 C, after it had been refrigerated overnight.
Total agglutinin nitrogen and group-specific agglutinin nitrogen were determined by quantitative agglutination, as described by Kabat Serology. Group-specific complement-fixing antibodies were produced in rabbits inoculated with lysed cell preparations ( Table 2 ). Although some cross-reactions occurred among the four serogroups, the homologous titers were 16-to 512-fold higher than the heterologous titers. These sera produced by inoculation with lysed cells were more group specific than were the antisera to whole cells (18) .
Precipitin reactions are summarized in Table 3 . Some cross-reaction occurred between group C antiserum and group E antigen. There were also some group C precipitins in group E antisera. Essentially, no cross-reaction was observed among groups A, B, or E.
The serological identity of the group E isolates and their relationship with the other serogroups were further demonstrated by cross-absorption experiments using the quantitative agglutination technique. The results ( Mouse-protection studies. Rabbit antisera to the four serogroups protected mice, as shown in Table 5 . The mouse-protective units in the homologous antisera ranged from 28 to 160. Group E antisera did not protect any of the mice challenged with groups A, B, or C. Mice challenged with strain SD4C were better protected by the homologous antiserum than they were by group E, strain Bo-6 antiserum.
Mice challenged with group E strain NOR-28 were not protected by 1 :10 dilution of antisera to groups A, B, or C (Table 6) Nonetheless, this study illustrates that the group E isolates are serologically distinct and that these isolates constitute a new serogroup of N. meningitidis. The group E strains are more closely related to group C than to either groups A or B, as indicated by precipitin and agglutinin tests. Initial serological grouping of isolates, as they were received, demonstrated no relationship between groups E and D strains. In addition, no crossreaction was noted between group E and group A, B, or C in the mouse-protection tests. This specificity corresponds to group A, which shows no correlation between its agglutinin titer in a serum and the capacity of that serum to protect mice (10) .
Studies are currently in progress to establish the relationship of group E to groups X, Y, and Z which were identified by Slaterus (14) .
